Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice
about
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor ActivityImproving the outcome of leukemia by natural killer cell-based immunotherapeutic strategiesNatural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspectiveInhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy.Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.Combined IL-15 and IL-12 drives the generation of CD34(+)-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transferHigh-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA statusHumanized Mouse Models of Clinical Disease.In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer.OP9 Feeder Cells Are Superior to M2-10B4 Cells for the Generation of Mature and Functional Natural Killer Cells from Umbilical Cord Hematopoietic Progenitors.The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications.In Vitro Generation of Human NK Cells Expressing Chimeric Antigen Receptor Through Differentiation of Gene-Modified Hematopoietic Stem Cells.Modeling Natural Killer Cell Targeted Immunotherapies.Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice.Programmed differentiated natural killer cells kill leukemia cells by engaging SLAM family receptors.Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cellsHuman Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse.Decitabine enhances targeting of AML cells by CD34+ progenitor-derived NK cells in NOD/SCID/IL2Rgnull mice.Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity.Expression of CD94 by -differentiated NK cells correlates with the and acquisition of cytotoxic featuresPeritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients
P2860
Q26773135-B5102746-90E9-40D2-812B-BB82F6CC8C73Q26996660-84732338-9D12-46E7-AF3A-FB9978C85DAFQ34180695-A9829E75-2989-4675-AD89-0E54C9FD912FQ34580132-249A8336-7392-4B97-B85E-5D6C2879DF85Q35600095-13C77D78-7B12-47E6-B0C0-9F63E4AC4A64Q35799180-2A33CE05-A4D3-4BFD-A65E-61F3EB85DBCAQ37575182-74CF19F0-096C-474D-82BC-778977BDC9A3Q37614202-E9CF0305-5E4C-4CBE-A8F4-A9BB510BC17EQ37625627-45EDCD0C-5B05-4E05-94F1-D6BF9F7EE50AQ38656761-C801A0DF-31AE-4E97-AFEC-F1EC33C8C21CQ38670431-94F32447-E8B2-445C-AC79-8044FF077853Q38733830-C878CC0F-AD83-4F32-8FC1-38A690EF768BQ38771094-7737F12E-F4F6-42DC-BB49-65F8E75F028CQ39239278-35EC4924-9968-40C9-8C9C-653419D9F284Q41337940-0ED54679-E513-45B5-B1C9-637794AE61B0Q41343418-B0F1E7DA-E3D8-4599-B0FA-C22BDEB0F042Q42556477-2ADD1F3D-04E0-452A-89CF-A95CB8C1151AQ46350666-AB4CC786-2741-4A78-8433-201647489D2AQ47156423-635BA99F-F2E0-4009-9B72-FB3854A2E35FQ47595821-D8BFDB7F-EE70-4D21-BC9D-5CBE1813BE84Q47821811-0EF3C800-AE46-49D8-A276-9AAFD3CDBEC3Q58125336-412ECD88-56A6-45B9-8431-923FB52083E8Q58582595-1176FBFA-0923-4CD5-86AF-BBEBFA1BAEBE
P2860
Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Natural killer cells generated ...... s in NOD/SCID/IL2Rg(null) mice
@ast
Natural killer cells generated ...... s in NOD/SCID/IL2Rg(null) mice
@en
Natural killer cells generated ...... s in NOD/SCID/IL2Rg(null) mice
@nl
type
label
Natural killer cells generated ...... s in NOD/SCID/IL2Rg(null) mice
@ast
Natural killer cells generated ...... s in NOD/SCID/IL2Rg(null) mice
@en
Natural killer cells generated ...... s in NOD/SCID/IL2Rg(null) mice
@nl
prefLabel
Natural killer cells generated ...... s in NOD/SCID/IL2Rg(null) mice
@ast
Natural killer cells generated ...... s in NOD/SCID/IL2Rg(null) mice
@en
Natural killer cells generated ...... s in NOD/SCID/IL2Rg(null) mice
@nl
P2093
P2860
P50
P1433
P1476
Natural killer cells generated ...... s in NOD/SCID/IL2Rg(null) mice
@en
P2093
Basav N Hangalapura
Gerben M Franssen
Jan Spanholtz
Jeannette Cany
Jolanda de Vries
Marleen Tordoir
Robbert van der Voort
P2860
P304
P356
10.1371/JOURNAL.PONE.0064384
P407
P577
2013-01-01T00:00:00Z